Every session you log, every shift you notice, every week you maintain a practice — that is data. Not raw numbers, but lived experience with structure around it. The question is not whether to generate it. You already are. The question is whether it contributes to something larger than your own journal.
Citizen science is the practice of structured, voluntary data collection by real people living real lives — not clinical subjects in a controlled environment. It has produced peer-reviewed research. It has changed how scientists understand what microdosing actually does at scale and in the wild. And it is exactly what the Evoke community is positioned to contribute to.
This page describes the opportunity, the methodology, the protections in place, and what participation means for you as a member. Nothing here is mandatory. Everything here is an invitation.
"The data that matters most for understanding microdosing does not come from a lab. It comes from people with practices — and the discipline to observe themselves honestly over time."
The Szigeti et al. self-blinding citizen science study, published in eLife, demonstrated that community-contributed structured data can produce publishable, peer-reviewed findings. Participants designed their own blinding protocol, collected their own data, and generated results that spoke directly to the limitations of the standard clinical model. Evoke's community is larger, more structured, and better positioned to do the same.
Structured voluntary data collection by community members living their ordinary lives. Not a clinical trial. Not a lab experiment. Real people, real conditions, real outcomes — organized under a consistent protocol so the data can be compared, aggregated, and analyzed.
Clinical trials cannot reach this population. The legal framework, the selection bias, the artificial conditions — they all exclude the most experienced, most intentional practitioners. Naturalistic data from a committed community fills a gap that institutional research simply cannot access.
Periodic completion of validated self-report instruments — mood, sleep, cognitive flexibility, integration quality. Takes ten minutes. Fully voluntary. All data is anonymized before it leaves your device. You can stop at any time without any effect on your membership.
Citizen science in psychedelic research is not speculative. It has produced published, peer-reviewed findings at major institutions. The studies below represent the landscape Evoke is positioned to contribute to — and eventually partner with.
Community participants designed their own blinding protocol, alternating between active and placebo microdoses without researcher intervention. First study of its kind. Demonstrated that citizen-designed methodology can produce publishable findings and identified the role of expectancy in microdosing outcomes.
Published in eLife. Cited in over 200 subsequent papers.Annual international survey collecting self-report data on drug use patterns, outcomes, and motivations. The microdosing module has produced the largest naturalistic dataset on who microdoses, why, what they report, and what goes wrong. Pure citizen science at scale.
Largest naturalistic microdosing dataset in existence.Demonstrated that psychedelics reopen social reward learning critical periods in animal models. Directly relevant to the context-biasing framework Evoke's formulations are built on. Community longitudinal data could provide the human correlate this paper points toward but cannot access.
Published in Nature. Foundational to the REBUS extension model.Double-blind placebo-controlled study with community participants self-administering in naturalistic conditions. Found no significant effects at sub-perceptual doses — a finding that directly supports Evoke's operationally defined perceptible dose framework and distinguishes it from ineffective microdosing protocols.
Bounds the sub-perceptual null hypothesis. Supports perceptible dose rationale.Evoke does not need institutional approval to begin collecting structured naturalistic data. The following study designs are available within the PMA framework today, with institutional partnership expanding what becomes possible over time.
Members complete validated self-report instruments at regular intervals over weeks and months. No intervention, no control group — just honest structured observation of what is already happening. This is the foundation of everything else.
MeasuresMembers self-report their dose tier alongside outcome measures. No randomization — members choose their own dose. But with enough participants across all five tiers, dose-response patterns become visible in the aggregate data. Real-world dose ecology.
Variables trackedThe study described in the Evoke theoretical manuscript: a 2x2 design varying botanical blend and experiential framing to separate pharmacological from expectancy effects. Requires institutional collaboration for IRB oversight and academic publication pathway.
DesignTests the core "from force to form" hypothesis: that durable change is a function of repeated consistent practice rather than acute dose intensity. Requires longitudinal tracking across cohorts with different protocol intensities and a structured integration support layer.
DesignCitizen science earns credibility through two things: validated measurement tools and institutional accountability. The instruments below are clinically established and widely used in psychedelic research. The institutions listed are active in this space and represent realistic partnership targets as Evoke's dataset develops.
Patient Health Questionnaire-9. Nine-item validated scale for depressive symptom severity. Standard in clinical and research settings. Short enough for regular completion without fatigue.
Generalized Anxiety Disorder 7-item scale. Validated, brief, widely used in psychedelic outcome research. Tracks anxiety across the practice cycle including before, during, and after protocol periods.
Pittsburgh Sleep Quality Index. 19-item self-report measuring sleep quality and disturbances over the prior month. Directly relevant to the consolidation phase framework and the Restore formulation's design targets.
Positive and Negative Affect Schedule. Measures positive and negative emotional states independently — useful because microdosing may increase positive affect without decreasing negative, or vice versa. Distinguishes effects that blunter scales miss.
Challenging Experience Questionnaire adapted for low-dose sessions. Captures the quality, character, and difficulty of individual sessions. Allows dose-response analysis by session rather than only over time.
Evoke-developed instrument measuring intention clarity, integration quality, behavioral follow-through, and archetype alignment. Not externally validated yet — developing internal validity through repeated use across the member cohort.
The following institutions are active in psychedelic research and represent realistic partnership targets. Evoke's naturalistic dataset — particularly the longitudinal integration quality data and context-biasing observations — fills gaps that none of these institutions can access through their own infrastructure.
Leading clinical psilocybin research. Published foundational work on therapeutic efficacy, mystical experience, and long-term outcomes. Primary interest in mechanism and clinical application.
Interdisciplinary research spanning neuroscience, philosophy, and social science. Actively interested in naturalistic and community-based data. Public engagement and citizen science aligned with their mission.
Focused on MDMA-assisted therapy but maintains broad research relationships. Drug policy, harm reduction, and community data all within scope. A bridge between community practice and institutional legitimacy.
Home of the Global Drug Survey and the self-blinding citizen science study. Direct precedent for the kind of work Evoke is positioned to contribute to. Active interest in naturalistic and self-report methodologies.
Ran the Szigeti self-blinding citizen science study. Demonstrated that community-designed methodology can produce peer-reviewed findings. The most direct institutional precedent for Evoke's research model.
Bridges indigenous knowledge, community practice, and academic research. Policy advocacy, harm reduction, and ethical frameworks. A natural partner for the ministry and PMA structure that governs Evoke's practice.
Participation in citizen science studies is voluntary, protected within the PMA framework, and comes with tangible benefits for the members who contribute. You are not a subject. You are a co-investigator in research about your own practice.
All data contributed through citizen science participation is held within the PMA framework. It is anonymized before aggregation, de-identified before any external sharing, and never sold, licensed, or disclosed to third parties without explicit member consent. Individual records are not accessible to researchers — only anonymized aggregate patterns.
You may withdraw your data at any time. Withdrawal removes your individual records from future analysis but does not affect already-aggregated findings. Participation has no bearing on your membership status, your level, or your access to any part of the ecosystem. It is an offering — not an obligation.
When Evoke pursues institutional partnerships, any formal research protocol will be reviewed under the applicable institutional ethics framework. Members participating in formal studies will provide separate informed consent specific to that protocol.
The first naturalistic observational study is being prepared now. Members who register interest will be the first contacted when enrolment opens. It takes ten minutes a week and builds something that matters beyond your own practice.
Register Interest Read the Science
